Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amkay ProductsBOM:544169 37 EBITDA Margin % is 6.04% as of Mar. 2026, which is 50% below its 10-year median of 11.97. GuruFocus rates BOM:544169 with a GF Score™ of 37/100. The stock has 2 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Amkay Products ranks better than 56.76% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Amkay Products's EBITDA for the
six
months ended in Mar. 2026 was ₹11.5 Mil. Amkay Products's Revenue for the
six
months ended in Mar. 2026 was ₹190.2 Mil. Therefore, Amkay Products's EBITDA margin for the quarter that ended in Mar. 2026 was 6.04%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Amkay Products EBITDA Margin % Related Terms
Amkay Products EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Amkay Products's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544169 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Amkay Products's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amkay Products EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Amkay Products's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Amkay Products's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amkay Products (BOM:544169) has a EBITDA Margin % of 6.04% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Amkay Products and its competitors. This is 50% below median its historical median of 11.97. Over the past decade, Amkay Products' EBITDA Margin % has ranged from 8.10 to 14.58. According to the industry distribution chart, Amkay Products ranks #352 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 43.2%.
Is Amkay Products' EBITDA Margin % too high?
Amkay Products' current EBITDA Margin % of 6.04% is 50% below median its 10-year median of 11.97. Over the past 10 years, this metric has ranged from a low of 8.10 to a high of 14.58. The Medical Devices & Instruments industry median EBITDA Margin % is 7.63. Amkay Products' value of 6.04% is 20.8% below this industry median. Based on the distribution chart, Amkay Products ranks #352 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Amkay Products has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Amkay Products' EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Amkay Products ranks #352 out of 814 companies for EBITDA Margin %. This puts Amkay Products in the upper half of its industry. The industry median EBITDA Margin % is 7.63. Amkay Products' value of 6.04% is 20.8% below this benchmark. Historically, Amkay Products' own EBITDA Margin % has ranged from 8.10 to 14.58 over the past decade. While the company's 10-year median is 11.97 vs. the industry median of 7.63, Amkay Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.63, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amkay Products's current EBITDA Margin % of 6.04% is 20.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Amkay Products and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amkay Products's current EBITDA Margin % is 6.04%, which is 50% below median its own 10-year median of 11.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amkay Products stock overvalued right now?
Amkay Products (BOM:544169) has a current EBITDA Margin % of 6.04%. The current EBITDA Margin % is 6.04%, which is 50% below median its 10-year median of 11.97 and 20.8% below the Medical Devices & Instruments industry median of 7.63. Amkay Products' overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Amkay Products (BOM:544169), the current EBITDA Margin % is 6.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amkay Products Ltd is a healthcare company. It manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. Additionally, engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.
37GF Score
Get the complete analysis for BOM:544169
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544169 has been successfully added to your 
